Low hair cortisol concentrations in obsessive compulsive disorder: A cross-sectional study

Autor: Aimilia Mantzou, Iraklis Mourikis, Maria Michou, Nikolaos Vaidakis, Iannis M. Zervas, Charalambos Papageorgiou, Thodoris Chalimourdas, Christina Darviri, Elli Koumantarou Malisiova, George P. Chrousos, Nikolaos Nianiakas

Publikováno v: Journal of Psychiatric Research. 131:187-193

Recent findings have highlighted the association between changes in the activity of the HPA axis, primarily its end-hormone, cortisol and OCD. However, to date, cortisol levels of OCD patients have been assessed mainly in body fluids, such as serum,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04d8ddadccd1323391204481ea57fd6b
https://doi.org/10.1016/j.jpsychires.2020.09.014

Associations Between Maternal Depression, Antidepressant Use During Pregnancy, and Adverse Pregnancy Outcomes: An Individual Participant Data Meta-analysis

Autor: Hedvig Nordeng, Dawn P. Misra, Katri Räikkönen, Marleen M.H.J. van Gelder, Claudia Holzman, Kate E. Pickett, Kiran Shaikh, Dan J. Stein, Liselott Andersson, Seyi Soremekun, Faruk Uguz, Tanja G. M. Vrijkotte, Marius Lahti-Pulkkinen, Ursula Winterfeld, Birit F.P. Broekman, H.J.H. Kuijpers, Heather J. Zar, Gal Dubnov-Raz, Stephanie L. Prady, Henning Tiemeier, J. Jo Kim, Frank M.M.A. van der Heijden, Anne Laure Sutter-Dallay, Nel Roeleveld, Shahirose Premji, Maria Niemi, Pinelopi Varela, Ali S. Khashan, Dan Mason, Jaime C. Slaughter-Acey, Janet L. Peacock, Judith B. Prins, Iannis M. Zervas, Mine Sahingoz, Richelle Vlenterie, H. Ross Anderson, Monica Pop-Purceleanu, Betty R. Kirkwood, Richard K. Silver, Ema Ferreira, Emma Fransson, Christine Rubertsson, Inger Sundström-Poromaa, Hanan El Marroun

Publikováno v: Obstetrics and Gynecology, 138(4), 633-646. Lippincott Williams and Wilkins
Obstetrics and Gynecology
Obstetrics and Gynecology, Lippincott, Williams & Wilkins, 2021, 138 (4), pp.633-646. ⟨10.1097/aog.0000000000004538⟩
Vlenterie, R, van Gelder, M M H J, Anderson, H R, Andersson, L, Broekman, B F P, Dubnov-Raz, G, El Marroun, H, Ferreira, E, Fransson, E, van der Heijden, F M M A, Holzman, C B, Kim, J J, Khashan, A S, Kirkwood, B R, Kuijpers, H J H, Lahti-Pulkkinen, M, Mason, D, Misra, D, Niemi, M, Nordeng, H M E, Peacock, J L, Pickett, K E, Prady, S L, Premji, S S, Räikkönen, K, Rubertsson, C, Sahingoz, M, Shaikh, K, Silver, R K, Slaughter-Acey, J, Soremekun, S, Stein, D J, Sundström-Poromaa, I, Sutter-Dallay, A L, Tiemeier, H, Uguz, F, Varela, P, Vrijkotte, T G M, Winterfeld, U, Zar, H J, Zervas, I M, Prins, J B, Pop-Purceleanu, M & Roeleveld, N 2021, ' Associations Between Maternal Depression, Antidepressant Use During Pregnancy, and Adverse Pregnancy Outcomes : An Individual Participant Data Meta-analysis ', Obstetrics and Gynecology, vol. 138, no. 4, pp. 633-646 . https://doi.org/10.1097/AOG.0000000000004538
Obstetrics and Gynecology, 138, 633-646
Obstetrics and gynecology, 138(4), 633-646. Lippincott Williams and Wilkins
Obstetrics and Gynecology, 138, 4, pp. 633-646

Item does not contain fulltext OBJECTIVE: To evaluate the associations of depressive symptoms and antidepressant use during pregnancy with the risks of preterm birth, low birth weight, small for gestational age (SGA), and low Apgar scores. DATA SOURC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96934ba325e33543f6709d14e5913dea
https://research.vumc.nl/en/publications/686d705f-43d6-4818-8bf7-190016654ccb

Management of depressive symptoms in peri- and postmenopausal women: EMAS position statement

Autor: Angelica Lindén Hirschberg, Antonio Cano, Risto Erkkola, Patrice Lopes, Vasilios Karageorgiou, Iannis M. Zervas, Areti C. Spyropoulou, Irene Lambrinoudaki, Fatih Durmusoglu, Dimitrios G. Goulis, Iuliana Ceausu, Ludwig Kiesel, Johannes Bitzer, Mick van Trotsenburg, Amos Pines, Margaret Rees, Peter Chedraui, Petra Stute

Publikováno v: Maturitas. 131

Introduction: Globally, the total number of people with depression exceeds 300 million, and the incidence rate is 70 % greater in women. The perimenopause is considered to be a time of increased risk for the development of depressive symptoms and maj

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae01ed6f676f67566aea9b3de4cbe65c
https://pubmed.ncbi.nlm.nih.gov/31740049

Schema therapy for patients with chronic depression: A single case series study

Autor: Artemios Pehlivanidis, George N. Papadimitriou, Aikaterini Aggeli, Ioannis A. Malogiannis, Miranda Vlavianou, Areti C. Spyropoulou, Spyridoula Karveli, Eirini Ι. Tsartsara, Iannis M. Zervas, Arnoud Arntz

Publikováno v: Journal of Behavior Therapy and Experimental Psychiatry, 45(3), 319-329. Elsevier
Journal of Behavior Therapy and Experimental Psychiatry, 45(3), 319-329. Elsevier Limited

Background and objectives This study tested the effectiveness of schema therapy (ST) for patients with chronic depression. Methods Twelve patients with a diagnosis of chronic depression participated. The treatment protocol consisted of 60 sessions, w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fecc1835a7184354e8105cc10f6dc63
https://doi.org/10.1016/j.jbtep.2014.02.003

Effects of escitalopram on stress-related relapses in women with multiple sclerosis: An open-label, randomized, controlled, one-year follow-up study

Autor: Constantin Potagas, George N. Papadimitriou, Demetrios Vassilopoulos, Iannis M. Zervas, Panagiotis Mitropoulos, Constantin Sfagos, Charalampos Mitsonis, Nikolaos Dimopoulos

Publikováno v: European Neuropsychopharmacology. 20:123-131

A growing body of evidence supports the association between Stressful Life Events (SLEs) and increased risk for relapse in Multiple Sclerosis (MS). In this open-label, randomized, controlled, one-year prospective study we investigated the effects of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::add8e6a7a39819073f3108736a1afb39
https://doi.org/10.1016/j.euroneuro.2009.10.004